A

Alexion

Global biopharmaceuticals focusing on rare diseases

Insight and Analytics Lead - Commercial Excellence

Business AnalysisConfirmed live in the last 24 hours
Full-timeMississauga, ON, Canada

About the Job

Requirements

  • A minimum of 6 years of experience in insights and data analytics within pharmaceuticals, healthcare, life sciences, or management consulting.
  • A bachelor's degree in business, management, analytics, or sciences is required.
  • Proven experience designing and managing primary market research.
  • Strong proficiency with R, Python, Power BI, and Tableau.
  • Deep knowledge of Canadian pharmaceutical data sources, including IQVIA, electronic medical records, claims data, TSA/TCR, CompuScript, Xponent, and CD&H.
  • Advanced quantitative modeling skills and the ability to apply frameworks that drive business decisions.
  • Demonstrated ability to generate insights from complex data and communicate findings clearly to executive audiences.
  • Ability to influence without direct authority and build consensus across departments and levels.
  • Project management capabilities to lead multiple initiatives simultaneously in a dynamic environment.

Responsibilities

  • Partner with Therapeutic Area leadership to deepen understanding of business and market dynamics, drive strategic decision-making, and ensure alignment with franchise objectives throughout the brand lifecycle.
  • Lead projects or cross-functional teams in designing and delivering insights, data analytics, and visualization solutions that address complex business challenges.
  • Translate stakeholder needs into actionable insight and data strategies, foster effective communication, and build collaborative relationships across functional areas.
  • Connect evidence, analytics, and business judgment to influence decisions across commercial, medical, market access, finance, supply, patient support, and regional or global teams.
  • Ensure insights are understood, adopted, and translated into measurable business actions.
  • Lead and establish the annual insights plan, informing brand strategy and therapeutic area decisions through primary market research, patient journey mapping, competitive intelligence, and voice of customer analysis.
  • Lead development of the annual Fact Book to support strategic planning and performance evaluation.
  • Guide forecasting processes by advancing insights into commercial assumptions and market dynamics.
  • Lead the brand insights process end-to-end, including budget oversight and vendor partnerships, ensuring timely delivery of high-quality research that illuminates market opportunities.
  • Shape strategies with regional and global stakeholders to leverage resources and deliver strategic milestones.
  • Lead insight generation across the brand lifecycle, including pre-launch planning, launch readiness, post-launch performance, indication expansion, market shaping, and lifecycle optimization.
  • Conduct quantitative analyses on patient data to uncover business opportunities and generate actionable insights.
  • Lead ad hoc analyses, including data visualizations that translate complex information into clear strategic recommendations.
  • Lead cross-functional workshops to align KPIs, metric definitions, and reporting standards.
  • Collaborate with Data Capabilities and IT teams to shape and prioritize critical reporting that supports strategic priorities.
  • Evaluate and recommend emerging technologies, including AI, to enhance analytical capabilities and competitive advantage.
  • Apply analytical methods including market sizing, patient-flow analysis, treatment-pathway analysis, segmentation, forecasting, scenario modeling, predictive analytics, and opportunity prioritization.

Desired Qualifications

  • A master's degree in business, management, marketing, health economics, epidemiology, biostatistics, data science, analytics, life sciences, or a related discipline is strongly preferred.
  • Experience in rare disease commercial landscapes.
  • Experience in rare disease, specialty pharmaceuticals, orphan drugs, or other complex healthcare markets.
  • Experience supporting product launches, launch readiness, indication expansion, market shaping, or brand lifecycle planning.
  • Strong understanding of the Canadian healthcare and pharmaceutical environment, including public and private reimbursement, provincial access differences, CADTH and INESSS processes, specialty distribution, and patient support programs.
  • Experience integrating claims, electronic medical records, prescription, sales, patient support, market research, and other healthcare data sources to generate a holistic view of patient and business dynamics.
  • Experience applying advanced methods such as forecasting, scenario modeling, patient-flow analysis, market sizing, segmentation, predictive analytics, or treatment pathway analysis.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs